MelaFind® System, designed by Electro-Optical Sciences, Inc., is thought to improve early diagnosis of melanoma. The company believes that once approved by the FDA, with “the assistance provided by MelaFind®, physicians could diagnose more melanomas at the earliest, curable stage, which would reduce both treatment costs and the number of unnecessary biopsies, and improve quality of life.” The technology is internet based:
The MelaFind® system is comprised of a point-of-care, hand-held imaging device that, in commercial use, is intended to be connected via the internet to a central server in our offices. MelaFind® employs multiple wavelengths of light to obtain data from images of suspicious pigmented skin lesions; the data are analyzed against our proprietary database of melanomas and benign lesions using our sophisticated algorithms. When marketed, a report will be transmitted to the physician’s office containing MelaFind®’s recommendation of whether the lesion should be biopsied.
Interesting product that we haven’t seen before. Unfortunately, according to Corante New York, the company has had a number of bad news lately.
Additional info about the product at Electro-Optical Sciences…